Washington, D.C. : United States. Dept. of Energy. ; Oak Ridge, Tenn. : distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy, 1982
Book — 1 online resource (Pages: 23 ) : digital, PDF file.
For a given intake mode (ingestion, inhalation, absorption through the skin), a dose conversion factor (DCF) is the committed dose equivalent to a specified organ of an individual per unit intake of a radionuclide. One also may consider the effective dose commitment per unit intake, which is a weighted average of organ-specific DCFs, with weights proportional to risks associated with stochastic radiation-induced fatal health effects, as defined by Publication 26 of the International Commission on Radiological Protection (ICRP). This report derives and tabulates organ-specific dose conversion factors and the effective dose commitment per unit intake of tritium. These factors are based on a steady-state model of hydrogen in the tissues of ICRP's Reference Man (ICRP Publication 23) and equilibrium of specific activities between body water and other tissues. The results differ by 27 to 33% from the estimate on which ICRP Publication 30 recommendations are based. The report also examines a dynamic model of tritium retention in body water, mineral bone, and two compartments representing organically-bound hydrogen. This model is compared with data from human subjects who were observed for extended periods. The manner of combining the dose conversion factors with measured or model-predicted levels of contamination in man's exposure media (air, drinking water, soil moisture) to estimate dose rate to an individual is briefly discussed.
Oak Ridge, Tenn. : Oak Ridge National Laboratory. ; Oak Ridge, Tenn. : distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy, 1982
Book — 1 online resource (Pages: 10 ) : digital, PDF file.
A model is presented for the internal radiation dose to the small intestine wall of miniature swine given Americium 241 citrate by oral intubation. The model incorporates the uptake of the Am-241 by the intestinal wall. About equal contributions of dose to the small intestine were observed from the intestinal contents and the wall itself. (ACR)
Oak Ridge, Tenn. : Oak Ridge National Laboratory. ; Oak Ridge, Tenn. : distributed by the Office of Scientific and Technical Information, U.S. Dept. of Energy, 1978
Book — 1 online resource (Pages: 16 ) : digital, PDF file.
A computer code, INREM II, was developed to calculate the internal radiation dose equivalent to organs of man which results from the intake of a radionuclide by inhalation or ingestion. Deposition and removal of radioactivity from the respiratory tract is represented by the Internal Commission on Radiological Protection Task Group Lung Model. A four-segment catenary model of the gastrointestinal tract is used to estimate movement of radioactive material that is ingested, or swallowed after being cleared from the respiratory tract. Retention of radioactivity in other organs is specified by linear combinations of decaying exponential functions. The formation and decay of radioactive daughters is treated explicitly, with each radionuclide in the decay chain having its own uptake and retention parameters, as supplied by the user. The dose equivalent to a target organ is computed as the sum of contributions from each source organ in which radioactivity is assumed to be situated. This calculation utilizes a matrix of dosimetric S-factors (rem/..mu..Ci-day) supplied by the user for the particular choice of source and target organs. Output permits the evaluation of components of dose from cross-irradiations when penetrating radiations are present. INREM II has been utilized with current radioactive decay data and metabolic models to produce extensive tabulations of dose conversion factors for a reference adult for approximately 150 radionuclides of interest in environmental assessments of light-water-reactor fuel cycles. These dose conversion factors represent the 50-year dose commitment per microcurie intake of a given radionuclide for 22target organs including contributions from specified source organs and surplus activity in the rest of the body. These tabulations are particularly significant in their consistent use of contemporary models and data and in the detail of documentation.